In Treatment of Severe acute pain Ultraspas Tablet effectively relieves sudden pain that is severe and bothersome. It helps treat muscle spasms or contractions in the stomach and intestine (gut), thereby relaxing the muscles and improving movement of food. It also blocks chemical messengers in the brain that are responsible for pain sensation. This helps to treat abdominal pain (or stomach pain) as well as cramps, bloating and discomfort. Take Ultraspas Tablet as prescribed to get maximum benefit. Eventually, it will help you to go about your daily activities more easily and have a more active and better quality of life.
It is unsafe to consume alcohol with Ultraspas Tablet.
Ultraspas Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Ultraspas Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Ultraspas Tablet may cause side effects which could affect your ability to drive. Ultraspas Tablet may cause side effects such as drowsiness and blurred vision. If this happens, do not drive.
Ultraspas Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ultraspas Tablet may be needed. Please consult your doctor.
Ultraspas Tablet should be used with caution in patients with liver disease. Dose adjustment of Ultraspas Tablet may be needed. Please consult your doctor.
If you miss a dose of Ultraspas Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Psychotropics India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Psychotropics India Ltd || ₹14.5/tablet (25% cheaper)